TABLE 2.
MDD Group (N=30) |
Control Group (N=25) |
|||
---|---|---|---|---|
N | % | N | % | |
Antidepressant | ||||
Amitriptyline | 1 | 3% | None | |
Bupropion | 4 | 13% | ||
Citalopram | 7 | 23% | ||
Doxepin | 1 | 3% | ||
Fluoxetine | 4 | 13% | ||
Imipramine | 1 | 3% | ||
Mirtazapine | 1 | 3% | ||
Nefazodone | 1 | 3% | ||
Nortriptyline | 2 | 7% | ||
Paroxetine | 4 | 13% | ||
Sertraline | 3 | 10% | ||
Trazodone | 17 | 57% | ||
Venlafaxine | 5 | 17% |
MDD: major depressive disorder; 60% of patients in the MDD group were prescribed more than one antidepressant medication.